Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017 (2017), Article ID 1276759, 6 pages
https://doi.org/10.1155/2017/1276759
Case Report

Polyneuropathy as Novel Initial Manifestation in a Case of “Nonsecretory” POEMS Syndrome with Sjögren’s Syndrome

1Division of Rheumatology, Huashan Hospital, Shanghai, China
2Institute of Rheumatology, Immunology and Allergy, Fudan University, Shanghai 200040, China
3Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, China
4Nursing Department, Huashan Hospital, Fudan University, Shanghai 200040, China

Correspondence should be addressed to Weiguo Wan; moc.anis@9691nawgw and Jun Liu; moc.nuyila@nujuilnahsauh

Received 9 July 2016; Revised 21 September 2016; Accepted 12 October 2016; Published 4 January 2017

Academic Editor: Arduino A. Mangoni

Copyright © 2017 Minrui Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Dispenzieri, “POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management,” American Journal of Hematology, vol. 89, no. 2, pp. 214–223, 2014. View at Google Scholar · View at Scopus
  2. S. C. Shiboski, C. H. Shiboski, L. Criswell et al., “American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort,” Arthritis Care & Research, vol. 64, no. 4, pp. 475–487, 2012. View at Google Scholar
  3. K. Glazebrook, F. L. Guerra Bonilla, A. Johnson, S. Leng, and A. Dispenzieri, “Computed tomography assessment of bone lesions in patients with POEMS syndrome,” European Radiology, vol. 25, no. 2, pp. 497–504, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Royer, L. Merlusca, J. Abraham et al., “Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients,” American Journal of Hematology, vol. 88, no. 3, pp. 207–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Minarik, V. Scudla, J. Bacovsky et al., “Comparison of imaging methods in POEMS syndrome,” Biomedical Papers, vol. 156, no. 1, pp. 52–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. P. F. Montoriol, F. Cachin, J. L. Michel, and M. Soubrier, “Two more cases of evaluation of POEMS syndrome using 18-FDG PET/CT,” European Journal of Radiology, vol. 80, no. 3, pp. 861–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Albertí, S. Martinez-Yélamos, A. Fernandez et al., “18F-FDG PET/CT in the evaluation of POEMS syndrome,” European Journal of Radiology, vol. 76, no. 2, pp. 180–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Saida, H. Kawakami, M. Ohta, and K. Iwamura, “Coagulation and vascular abnormalities in Crow-Fukase syndrome,” Muscle & Nerve, vol. 20, no. 4, pp. 486–492, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Scarlato, S. C. Previtali, M. Carpo et al., “Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis,” Brain, vol. 128, no. 8, pp. 1911–1920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Stankowski-Drengler, M. A. Gertz, J. A. Katzmann et al., “Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome,” American Journal of Hematology, vol. 85, no. 6, pp. 431–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Brewis, A. C. Church, A. J. Peacock, S. Thomson, J. Tighe, and M. K. Johnson, “Pulmonary hypertension in POEMS syndrome: resolution following radiotherapy,” Pulmonary Circulation, vol. 4, no. 4, pp. 732–735, 2014. View at Publisher · View at Google Scholar
  12. I. A. Grant, G. G. Hunder, H. A. Homburger, and P. J. Dyck, “Peripheral neuropathy associated with sicca complex,” Neurology, vol. 48, no. 4, pp. 855–862, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Mori, M. Iijima, H. Koike et al., “The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy,” Brain, vol. 128, no. 11, pp. 2518–2534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Brito-Zerón, M. Akasbi, X. Bosch et al., “Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome,” Clinical and Experimental Rheumatology, vol. 31, no. 1, pp. 103–110, 2013. View at Google Scholar · View at Scopus
  15. S. Delalande, J. de Seze, A.-L. Fauchais et al., “Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients,” Medicine, vol. 83, no. 5, pp. 280–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. P. Pavlakis, H. Alexopoulos, M. L. Kosmidis et al., “Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms,” Journal of Autoimmunity, vol. 39, no. 1-2, pp. 27–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Dalakas, “Advances in the diagnosis, pathogenesis and treatment of CIDP,” Nature Reviews Neurology, vol. 7, no. 9, pp. 507–517, 2011. View at Publisher · View at Google Scholar · View at Scopus